Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Overview
Pro stress-test →Fosun Pharma, established in 1994 and listed on Shanghai Stock Exchange (600196), is a leading healthcare group covering pharmaceutical manufacturing and R&D, healthcare services, medical devices, medical diagnostics, and pharmaceutical distribution and retail. The company maintains pharmaceutical manufacturing and R&D as its core business, with healthcare services as the development focus.
Strategic Profile
Pro stress-test →Fosun Pharma is implementing its 4IN strategy—Innovation, Internationalization, Intelligentization, and Integration—with core operations spanning major overseas markets including the United States, Europe, Africa, India, and Southeast Asia. The company has developed international R&D teams across China, the United States, and India, establishing platforms for innovative chemical drugs, biologics, high-value generic drugs, and cell therapy.
Competitive Landscape
Pro stress-test →Fosun Pharma competes in China's highly competitive pharmaceutical market with domestic players like China Biologic Products, China Pharma Holdings, and Luokang High-tech, as well as multinational pharma companies. The company differentiates through its diversified portfolio spanning innovative drugs, generics, medical devices, diagnostics, and integrated healthcare services.
Industry Context
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. operates in Pharmaceutical manufacturing and R&D.
Key facts
Founded: 1994 · Headquarters: Shanghai, China · Employees: 40,603 · Revenue: $5.8B (2024) · Market cap: $7.9B